# EDGAR Filing Document

**Accession Number:** 0001302215
**File Stem:** 0001302215-23-000003
**Filing Date:** 2023-2
**Character Count:** 32609
**Document Hash:** 31c145dc86cde5d43bfe82984e654d5a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001302215-23-000003.hdr.sgml**: 20230201

**ACCESSION NUMBER**: 0001302215-23-000003

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230131

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230201

**DATE AS OF CHANGE**: 20230131

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HOULIHAN LOKEY, INC.
- **CENTRAL INDEX KEY:** 0001302215
- **STANDARD INDUSTRIAL CLASSIFICATION:** INVESTMENT ADVICE [6282]
- **IRS NUMBER:** 952770395
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37537
- **FILM NUMBER:** 23574200

**BUSINESS ADDRESS:**
- **STREET 1:** HOULIHAN LOKEY, INC.
- **STREET 2:** 10250 CONSTELLATION BLVD., 5TH FLOOR
- **CITY:** LOS ANGELES
- **STATE:** CA
- **ZIP:** 90067
- **BUSINESS PHONE:** 310.553.8871

**MAIL ADDRESS:**
- **STREET 1:** HOULIHAN LOKEY, INC.
- **STREET 2:** 10250 CONSTELLATION BLVD., 5TH FLOOR
- **CITY:** LOS ANGELES
- **STATE:** CA
- **ZIP:** 90067

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HOULIHAN LOKEY HOWARD & ZUKIN INC
- **DATE OF NAME CHANGE:** 20040902

?xml version="1.0" ? hli-20230131

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, DC 20549**

**FORM 8-K** 

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(d) OF THE**

**SECURITIES EXCHANGE ACT OF 1934**

Date of report (Date of earliest event reported):

January 31, 2023

**Houlihan Lokey, Inc.**

(Exact Name of Registrant as Specified in Charter)

---

| | | |
|:---|:---|:---|
| Delaware | **001-37537** | 95-2770395 |
| (State or Other Jurisdiction of<br>Incorporation) | (Commission File Number) | (IRS Employer<br>Identification No.) |

---

**10250 Constellation Blvd.** 

**5**<sup>th</sup> **Floor** 

**Los Angeles, California 90067** 

**(Address of principal executive offices) (Zip Code)**

310-788-5200

Registrant's telephone number, including area code:

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (*see* General Instruction A.2. below):

☐&nbsp;&nbsp;&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐&nbsp;&nbsp;&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of Each Class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Class A Common Stock, par value $0.001 | HLI | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

------

**Item 2.02.&nbsp;&nbsp;&nbsp;&nbsp;Results of Operations and Financial Condition.**

On January 31, 2023, Houlihan Lokey, Inc. issued a press release announcing its financial results for the third fiscal quarter ended December 31, 2022. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

The information in Item 2.02 of this Current Report on Form 8-K, including the information contained in Exhibit 99.1, is being furnished to the Securities and Exchange Commission pursuant to Item 2.02, and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by a specific reference in such filing.

**Item 9.01.&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.**

(d) Exhibits

99.1&nbsp;&nbsp;&nbsp;&nbsp;<u>[Press Release dated January 31, 2023](q3fy23-ex991.htm)</u>

104&nbsp;&nbsp;&nbsp;&nbsp;Cover Page Interactive Data File (embedded within the Inline XBRL document)

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| Date: | January 31, 2023 | Houlihan Lokey, Inc. | Houlihan Lokey, Inc. |
|  |  | By: | /s/ J. Lindsey Alley |
|  |  |  | Name: J. Lindsey Alley |
|  |  |  | Position: Chief Financial Officer |

---

------

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| <u>Exhibit No.</u> | <u>Description</u> |
| 99.1 | <u>[Press Release dated January 31, 2023](q3fy23-ex991.htm)</u> |

---

## Exhibit 99.1

![hllogo2022.jpg](hllogo2022.jpg)

**Houlihan Lokey Reports Third Quarter Fiscal 2023 Financial Results**

**–** *Third Quarter Fiscal 2023 Revenues of $456 million* **–**

**–** *Third Quarter Fiscal 2023 Diluted EPS of $0.90* **–**

**–** *Adjusted Third Quarter Fiscal 2023 Diluted EPS of $1.14* **–**

**–** *Announces Dividend of $0.53 per Share for Fourth Quarter Fiscal 2023* **–**

**LOS ANGELES and NEW YORK *-* January 31, 2023** *-* Houlihan Lokey, Inc. (NYSE:HLI) ("Houlihan Lokey" or the "Company") today reported financial results for its third quarter ended December 31, 2022.

For the third quarter ended December 31, 2022, revenues were $456 million, compared with $889 million for the third quarter ended December 31, 2021. Net income was $63 million, or $0.90 per diluted share, for the third quarter ended December 31, 2022, compared with $174 million, or $2.54 per diluted share, for the third quarter ended December 31, 2021. Adjusted net income for the third quarter ended December 31, 2022 was $79 million, or $1.14 per diluted share, compared with $198 million, or $2.90 per diluted share, for the third quarter ended December 31, 2021.

"Houlihan Lokey continues to operate in a challenging M&A environment, which negatively impacted our third quarter fiscal 2023 results. However, once again the firm distinguished itself in the industry in calendar year 2022. I am proud to announce that in 2022 we were recognized as the #1 M&A advisor globally based on number of completed transactions, the #1 restructuring advisor globally based on both the number of completed transactions and value, and the #1 most active fairness opinion advisor by volume for the past 25 years, per Refinitiv. The firm is well poised to continue its long term growth profile when the market dynamics improve." stated Scott Beiser, Chief Executive Officer of Houlihan Lokey.

**Selected Financial Data**

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***<u>(In thousands, except per share data)</u>*** | **U.S. GAAP** | **U.S. GAAP** | **U.S. GAAP** | **U.S. GAAP** |
| ***<u>(In thousands, except per share data)</u>*** | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Nine Months Ended December 31,** | **Nine Months Ended December 31,** |
| ***<u>(In thousands, except per share data)</u>*** | **2022** | **2021** | **2022** | **2021** |
| Revenues by segment |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Corporate Finance | $291734 | $715663 | $870701 | $1314064 |
| &nbsp;&nbsp;&nbsp;Financial Restructuring | 98819 | 89273 | 275351 | 271232 |
| &nbsp;&nbsp;&nbsp;Financial and Valuation Advisory | 65946 | 83862 | 218628 | 213496 |
| Revenues | $456499 | $888798 | $1364680 | $1798792 |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Employee compensation and benefits | $289348 | $549376 | $864942 | $1115054 |
| &nbsp;&nbsp;&nbsp;Non-compensation | 82978 | 90162 | 248624 | 169483 |
| Operating income | 84173 | 249260 | 251114 | 514255 |
| &nbsp;&nbsp;&nbsp;Other expense, net | 563 | 253 | 7416 | 1005 |
| Income before provision for income taxes | 83610 | 249007 | 243698 | 513250 |
| &nbsp;&nbsp;&nbsp;Provision for income taxes | 20559 | 74699 | 49135 | 140099 |
| Net income | $63051 | $174308 | $194563 | $373151 |
| &nbsp;&nbsp;&nbsp;Net income attributable to noncontrolling interest |  | (573) |  | (573) |
| Net income attributable to Houlihan Lokey, Inc. | $63051 | $173735 | $194563 | $372578 |
| Diluted earnings per share attributable to Houlihan Lokey, Inc. | $0.90 | $2.54 | $2.80 | $5.44 |

---

------

![hllogo2022.jpg](hllogo2022.jpg)

**Revenues**

For the third quarter ended December 31, 2022, revenues were $456 million, compared with $889 million for the third quarter ended December 31, 2021. Revenues decreased primarily as a result of a decrease in the number of closed transactions. For the third quarter ended December 31, 2022, Corporate Finance ("CF") revenues decreased (59)%, Financial Restructuring ("FR") revenues increased 11%, and Financial and Valuation Advisory ("FVA") revenues decreased (21)% when compared with the third quarter ended December 31, 2021.

**Expenses**

The Company's employee compensation and benefits expenses, non-compensation expenses, and provision for income taxes during the periods presented and described below are on a GAAP and an adjusted basis.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **U.S. GAAP** | **U.S. GAAP** | **Adjusted (Non-GAAP) \*** | **Adjusted (Non-GAAP) \*** |
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Three Months Ended December 31,** |
| ***<u>($ in thousands)</u>*** | **2022** | **2021** | **2022** | **2021** |
| **Expenses:** |  |  |  |  |
| Employee compensation and benefits | $289348 | $549376 | $280749 | $546611 |
| &nbsp;&nbsp;&nbsp;&nbsp;*% of Revenues* | *63.4 %* | *61.8 %* | *61.5 %* | *61.5 %* |
| Non-compensation | $82978 | $90162 | $72611 | $58543 |
| &nbsp;&nbsp;&nbsp;&nbsp;*% of Revenues* | *18.2 %* | *10.1 %* | *15.9 %* | *6.6 %* |
| Provision for income taxes | $20559 | $74699 | $25897 | $85014 |
| &nbsp;&nbsp;&nbsp;&nbsp;*% of Pre-tax income* | *24.6 %* | *30.0 %* | *24.6 %* | *30.0 %* |

---

\*Adjusted figures represent non-GAAP information. See "Non-GAAP Financial Measures" and the tables at the end of this release for an explanation of the adjustments and reconciliations to the comparable GAAP numbers.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **U.S. GAAP** | **U.S. GAAP** | **Adjusted (Non-GAAP) \*** | **Adjusted (Non-GAAP) \*** |
| | **Nine Months Ended December 31,** | **Nine Months Ended December 31,** | **Nine Months Ended December 31,** | **Nine Months Ended December 31,** |
| ***<u>($ in thousands)</u>*** | **2022** | **2021** | **2022** | **2021** |
| **Expenses:** |  |  |  |  |
| Employee compensation and benefits | $864942 | $1115054 | $839279 | $1106257 |
| &nbsp;&nbsp;&nbsp;&nbsp;*% of Revenues* | *63.4 %* | *62.0 %* | *61.5 %* | *61.5 %* |
| Non-compensation | $248624 | $169483 | $204543 | $133548 |
| &nbsp;&nbsp;&nbsp;&nbsp;*% of Revenues* | *18.2 %* | *9.4 %* | *15.0 %* | *7.4 %* |
| Provision for income taxes | $49135 | $140099 | $83186 | $160169 |
| &nbsp;&nbsp;&nbsp;&nbsp;*% of Pre-tax income* | *20.2 %* | *27.3 %* | *25.9 %* | *28.7 %* |

---

\*Adjusted figures represent non-GAAP information. See "Non-GAAP Financial Measures" and the tables at the end of this release for an explanation of the adjustments and reconciliations to the comparable GAAP numbers.

Employee compensation and benefits expenses were $289 million for the third quarter ended December 31, 2022, compared with $549 million for the third quarter ended December 31, 2021. Adjusted employee compensation and benefits expenses were $281 million for the third quarter ended December 31, 2022, compared with $547 million for the third quarter ended December 31, 2021. This resulted in an adjusted compensation ratio of 61.5% for both the third quarter ended December 31, 2022 and the third quarter ended December 31, 2021. The decrease in GAAP and adjusted employee compensation and benefits expenses was a result of a decrease in fee revenues for the quarter when compared with the same quarter last year.

------

![hllogo2022.jpg](hllogo2022.jpg)

Non-compensation expenses were $83 million for the third quarter ended December 31, 2022, compared with $90 million for the third quarter ended December 31, 2021. The decrease in GAAP non-compensation expenses was primarily a result of a decrease in depreciation and amortization and a decrease in professional fees for the quarter when compared with the same quarter last year. Adjusted non-compensation expenses were $73 million for the third quarter ended December 31, 2022, compared with $59 million for the third quarter ended December 31, 2021. The increase in adjusted non-compensation expenses was primarily a result of an increase in travel, meals, and entertainment expenses and other operating expenses.

The provision for income taxes was $21 million, representing an effective tax rate of 24.6% for the third quarter ended December 31, 2022, compared with $75 million, representing an effective tax rate of 30.0% for the third quarter ended December 31, 2021. The decrease in the Company's tax rate during the three months ended December 31, 2022 relative to the same period in 2021 was primarily the result of decreased state taxes and decreased taxes due to foreign operations.

**Segment Reporting for the Third Fiscal Quarter**

*<u>Corporate Finance</u>*

CF revenues were $292 million for the third quarter ended December 31, 2022, compared with $716 million for the third quarter ended December 31, 2021, representing a decrease of (59)%. Revenues decreased primarily due to a decrease in the number of closed transactions and a decrease in the average transaction fee on closed transactions.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Nine Months Ended December 31,** | **Nine Months Ended December 31,** |
| ***<u>($ in thousands)</u>*** | **2022** | **2021** | **2022** | **2021** |
| **Corporate Finance** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Revenues | $291734 | $715663 | $870701 | $1314064 |
| &nbsp;&nbsp;&nbsp;&nbsp;# of Managing Directors | 215 | 198 | 215 | 198 |
| &nbsp;&nbsp;&nbsp;&nbsp;# of Closed transactions <sup>(1)</sup> | 125 | 238 | 363 | 456 |

---

*<u>Financial Restructuring</u>*

FR revenues increased 11% to $99 million for the third quarter ended December 31, 2022, compared with $89 million for the third quarter ended December 31, 2021. Revenues increased primarily due to an increase in the number of closed transactions during the quarter, partially offset by a decrease in the average transaction fee on closed transactions during the quarter.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Nine Months Ended December 31,** | **Nine Months Ended December 31,** |
| ***<u>($ in thousands)</u>*** | **2022** | **2021** | **2022** | **2021** |
| **Financial Restructuring** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Revenues | $98819 | $89273 | $275351 | $271232 |
| &nbsp;&nbsp;&nbsp;&nbsp;# of Managing Directors | 56 | 52 | 56 | 52 |
| &nbsp;&nbsp;&nbsp;&nbsp;# of Closed transactions <sup>(1)</sup> | 28 | 21 | 68 | 65 |

---

*<u>Financial and Valuation Advisory</u>*

FVA revenues decreased (21)% to $66 million for the third quarter ended December 31, 2022, compared with $84 million for the third quarter ended December 31, 2021. Revenues decreased primarily due to a decrease in the average fee per fee event.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Nine Months Ended December 31,** | **Nine Months Ended December 31,** |
| ***<u>($ in thousands)</u>*** | **2022** | **2021** | **2022** | **2021** |
| **Financial and Valuation Advisory** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Revenues | $65946 | $83862 | $218628 | $213496 |
| &nbsp;&nbsp;&nbsp;&nbsp;# of Managing Directors | 38 | 34 | 38 | 34 |
| &nbsp;&nbsp;&nbsp;&nbsp;# of Fee Events <sup>(1)</sup> | 876 | 901 | 1815 | 1673 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(1)A Fee Event includes any engagement that involves revenue activity during the measurement period based on a revenue minimum of one thousand dollars. References in this press release to closed transactions should be understood to be the same as transactions that are "effectively closed" as described in our periodic reports on Forms 10-K and 10-Q.*

------

![hllogo2022.jpg](hllogo2022.jpg)

**Balance Sheet and Capital Allocation**

The Board of Directors of the Company declared a regular quarterly cash dividend of $0.53 per share of Class A and Class B common stock. The dividend will be payable on March 15, 2023 to stockholders of record as of the close of business on March 2, 2023. As of December 31, 2022, the Company had $586 million of cash and cash equivalents and investment securities, and $47 million of other liabilities and loans payable to former shareholders.

**Investor Conference Call and Webcast**

The Company will host a conference call and live webcast at 5:00 p.m. Eastern Time on Tuesday, January 31, 2023, to discuss its third quarter fiscal 2023 results. The number to call is 1-888-394-8218 (domestic) or 1-646-828-8193 (international). A live webcast will be available in the Investor Relations section of the Company's website. A replay of the conference call will be available from January 31, 2023 through February 7, 2023, by dialing 1-844-512-2921 (domestic) or 1-412-317-6671 (international) and entering the passcode 1668989#. A replay of the webcast will be archived and available on the Company's website.

**Forward-Looking Statements**

This press release contains forward-looking statements within the meaning of the federal securities laws. You can identify these statements by our use of the words "assumes," "believes," "estimates," "expects," "guidance," "intends," "plans," "projects," and similar expressions that do not relate to historical matters. You should exercise caution in interpreting and relying on forward-looking statements because they involve known and unknown risks, uncertainties, and other factors which are, in some cases, beyond the Company's control and could materially affect actual results, performance, or achievements. For a further description of such factors, you should read the Company's filings with the Securities and Exchange Commission. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. The Company does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

**Non-GAAP Financial Measures**

Adjusted net income, total and on a per share basis, and certain adjusted items used to determine adjusted net income, are presented and discussed in this earnings press release and are non-GAAP measures that management believes, when presented together with comparable GAAP measures, are useful to investors in understanding the Company's operating results. These adjusted items remove the significant accounting impact of one-time or non-recurring charges associated with the Company's one-time/non-recurring matters, as set forth in the tables at the end of this release.

The adjusted items included in this earnings press release as calculated by the Company are not necessarily comparable to similarly titled measures reported by other companies. Additionally, these adjusted amounts are not a measurement of financial performance or liquidity under GAAP and should not be considered as an alternative to the Company's financial information determined under GAAP. For a description of the Company's use of these adjusted items and a reconciliation with comparable GAAP items, see the section of this press release titled "Reconciliation of GAAP to Adjusted Financial Information." Please refer to our financial statements, prepared in accordance with GAAP, for purposes of evaluating our financial condition, results of operations, and cash flows.

**About Houlihan Lokey**

Houlihan Lokey (NYSE:HLI) is a global investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, and financial and valuation advisory. The firm serves corporations, institutions, and governments worldwide with offices in the United States, Europe, the Middle East, and the Asia-Pacific region. Independent advice and intellectual rigor are hallmarks of the firm's commitment to client success across its advisory services. Houlihan Lokey is the No. 1 investment bank for global M&A transactions under $1 billion, the No. 1 M&A advisor for the past eight consecutive years in the U.S., the No. 1 global restructuring advisor for the past nine consecutive years, and the No. 1 global M&A fairness opinion advisor over the past 25 years, all based on number of transactions and according to data provided by Refinitiv.

For more information, please visit www.HL.com.

------

![hllogo2022.jpg](hllogo2022.jpg)

**Contact Information**

Investor Relations<br>212.331.8225<br>IR@HL.com OR Public Relations<br>212.331.8223<br>PR@HL.com

**Appendix**

Condensed Consolidated Balance Sheets (Unaudited)

Condensed Consolidated Statements of Income (Unaudited)

Reconciliation of GAAP to Adjusted Financial Information (Unaudited)

------

![hllogo2022.jpg](hllogo2022.jpg)

**HOULIHAN LOKEY, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED BALANCE SHEETS** 

**(UNAUDITED)**

---

| | | |
|:---|:---|:---|
| ***<u>(In thousands, except share data and par value)</u>*** | **December 31, 2022** | **March 31, 2022** |
| Assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $549422 | $833697 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restricted cash | 373 | 373 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investment securities | 36775 | 109143 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net of allowance for credit losses | 138028 | 144029 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unbilled work in process, net of allowance for credit losses | 152052 | 104751 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes receivable | 9864 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | 112726 | 95278 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property and equipment, net | 75624 | 52176 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease right-of-use assets | 255725 | 171942 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 1060666 | 1070442 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other intangible assets, net | 204845 | 247333 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets | 75542 | 57646 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $2671642 | $2886810 |
| Liabilities and Stockholders' Equity |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued salaries and bonuses | $638646 | $953604 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | 119974 | 126190 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income | 40576 | 28753 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable |  | 61266 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | 619 | 789 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loans payable to former shareholders | 307 | 539 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | 283728 | 197091 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other liabilities | 47135 | 74873 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 1130985 | 1443105 |
| Stockholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class A common stock, $0.001 par value. Authorized 1,000,000,000 shares; issued and outstanding 50,351,143 and 49,853,564 shares, respectively | 50 | 50 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class B common stock, $0.001 par value. Authorized 1,000,000,000 shares; issued and outstanding 18,271,833 and 17,649,555 shares, respectively | 18 | 18 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 602349 | 564761 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 1008246 | 922223 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (70006) | (43347) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 1540657 | 1443705 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' equity | $2671642 | $2886810 |

---

------

![hllogo2022.jpg](hllogo2022.jpg)

**HOULIHAN LOKEY, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF INCOME** 

**(UNAUDITED)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Nine Months Ended December 31,** | **Nine Months Ended December 31,** |
| ***<u>(In thousands, except share and per share data)</u>*** | **2022** | **2021** | **2022** | **2021** |
| Revenues | $456499 | $888798 | $1364680 | $1798792 |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Employee compensation and benefits | 289348 | 549376 | 864942 | 1115054 |
| &nbsp;&nbsp;&nbsp;&nbsp;Travel, meals, and entertainment | 14271 | 11090 | 37691 | 17464 |
| &nbsp;&nbsp;&nbsp;&nbsp;Rent | 12852 | 14352 | 37927 | 33627 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 13256 | 20074 | 51874 | 28589 |
| &nbsp;&nbsp;&nbsp;&nbsp;Information technology and communications | 14751 | 12398 | 38924 | 28217 |
| &nbsp;&nbsp;&nbsp;&nbsp;Professional fees | 7795 | 14372 | 23862 | 27988 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other operating expenses | 20053 | 17876 | 58346 | 33598 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 372326 | 639538 | 1113566 | 1284537 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating income | 84173 | 249260 | 251114 | 514255 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expense, net | 563 | 253 | 7416 | 1005 |
| Income before provision for income taxes | 83610 | 249007 | 243698 | 513250 |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for income taxes | 20559 | 74699 | 49135 | 140099 |
| Net income | 63051 | 174308 | 194563 | 373151 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to noncontrolling interest |  | (573) |  | (573) |
| Net income attributable to Houlihan Lokey, Inc. | $63051 | $173735 | $194563 | $372578 |
| Weighted average shares of common stock outstanding: | Weighted average shares of common stock outstanding: | Weighted average shares of common stock outstanding: | Weighted average shares of common stock outstanding: | Weighted average shares of common stock outstanding: |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 63381024 | 64914373 | 63360741 | 65259927 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fully diluted | 69725692 | 68279939 | 69453588 | 68520849 |
| Earnings per share attributable to Houlihan Lokey, Inc. |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.99 | $2.68 | $3.07 | $5.71 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fully diluted | $0.90 | $2.54 | $2.80 | $5.44 |

---

------

![hllogo2022.jpg](hllogo2022.jpg)

**HOULIHAN LOKEY, INC. AND SUBSIDIARIES**

**RECONCILIATION OF GAAP TO ADJUSTED FINANCIAL INFORMATION**

**(UNAUDITED)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Nine Months Ended December 31,** | **Nine Months Ended December 31,** |
| ***<u>(In thousands, except per share data)</u>*** | **2022** | **2021** | **2022** | **2021** |
| ***Revenues*** | $456499 | $888798 | $1364680 | $1798792 |
| ***Employee compensation and benefits expenses*** |  |  |  |  |
| Employee compensation and benefits expenses (GAAP) | $289348 | $549376 | $864942 | $1115054 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Acquisition related retention payments | (8599) | (2765) | (25663) | (8797) |
| Employee compensation and benefits expenses (adjusted) | 280749 | 546611 | 839279 | 1106257 |
| ***Non-compensation expenses*** |  |  |  |  |
| Non-compensation expenses (GAAP) | $82978 | $90162 | $248624 | $169483 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Integration and acquisition related costs |  | (16165) | (2325) | (17805) |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Acquisition amortization | (10367) | (15454) | (41756) | (18130) |
| Non-compensation expenses (adjusted) | 72611 | 58543 | 204543 | 133548 |
| ***Operating income*** |  |  |  |  |
| Operating income (GAAP) | $84173 | $249260 | $251114 | $514255 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Adjustments <sup>(1)</sup> | 18966 | 34384 | 69744 | 44732 |
| Operating income (adjusted) | 103139 | 283644 | 320858 | 558987 |
| ***Other expense, net*** |  |  |  |  |
| Other expense, net (GAAP) | $563 | $253 | $7416 | $1005 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Warrant revaluation |  |  | (2264) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: SPAC wind-down write-off | (2742) |  | (2742) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Increase in acquisition earnout liability |  |  | (2841) |  |
| Other (income)/expense, net (adjusted) | (2179) | 253 | (431) | 1005 |
| ***Provision for income taxes*** |  |  |  |  |
| Provision for income taxes (GAAP) | $20559 | $74699 | $49135 | $140099 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Impact of the excess tax benefit for stock vesting |  |  | 8102 | 6922 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Release of the provision for an uncertain tax position as a result of the successful closure of a state audit |  |  | 5762 |  |
| &nbsp;&nbsp;&nbsp;Adjusted provision for income taxes | 20559 | 74699 | 62999 | 147021 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Resulting tax impact <sup>(2)</sup> | 5338 | 10315 | 20187 | 13148 |
| Provision for income taxes (adjusted) | 25897 | 85014 | 83186 | 160169 |
| ***Net income*** |  |  |  |  |
| Net income (GAAP) | $63051 | $174308 | $194563 | $373151 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Adjustments <sup>(3)</sup> | 16370 | 24069 | 43540 | 24662 |
| Net income (adjusted) | 79421 | 198377 | 238103 | 397813 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to noncontrolling interest |  | (573) |  | (573) |
| Net income attributable to Houlihan Lokey, Inc. (GAAP) | 63051 | 173735 | 194563 | 372578 |
| Net income attributable to Houlihan Lokey, Inc. (adjusted) | 79421 | 197804 | 238103 | 397240 |
| Diluted EPS attributable to Houlihan Lokey, Inc. (GAAP) | $0.90 | $2.54 | $2.80 | $5.44 |
| Diluted EPS attributable to Houlihan Lokey, Inc. (adjusted) | $1.14 | $2.90 | $3.43 | $5.79 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The aggregate of adjustments from employee compensation and benefits and non-compensation expenses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Reflects the tax impact of utilizing the adjusted effective tax rate on the non-tax adjustments identified above.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)Consists of all adjustments identified above net of the associated tax impact.